Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Fresnillo sells down MAG Silver stake

(Sharecast News) - Fresnillo has sold the majority of its stake in MAG Silver, it said on Friday, following the announcement of a proposed acquisition of MAG by Pan American Silver. The precious metals miner said its initial investment in MAG Silver was made to support the development of the Juanicipio mine, where Fresnillo is operator and majority owner.

Under the terms of the proposed deal, Fresnillo's 9% holding in MAG would be diluted to less than 1% in Pan American.

The company emphasised its continued confidence in the performance and long-term value of Juanicipio, which it described as a key asset in its portfolio.

It added that the sale of shares reflected a disciplined investment approach, with proceeds to be used in line with Fresnillo's capital allocation priorities, including growth projects and maintaining balance sheet strength.

Fresnillo said it was looking forward to working with Pan American at Juanicipio should the acquisition complete, but confirmed that governance and legal terms of the mine's partnership remain unchanged.

At 0809 BST, shares in Fresnillo were down 0.3% at 1,013p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.